In the press Archives

RescuePatch is a unique, controlled-release combination patch that delivers both naloxone and flumazenil, antidotes for opioid and benzodiazepine overdoses, respectively. Developed by MESOX, this solution addresses a critical gap in emergency response by empowering anyone, even without medical training, to administer life-saving antidote treatments.

This recognition underscores MESOX’s dedication to leveraging advanced technology to tackle the urgent public health crisis of drug-related deaths.

In January 2021, the Scottish Government announced a National Mission on Drugs. The aim of the national mission is to reduce drug deaths and improve the lives of those impacted by drugs in a programme of work supported by the Drug Deaths Taskforce and the National Mission on Drugs plan. The demand-signalling work of the Chief Scientist Office innovation team, based on the Care and Wellbeing Programme, identified tackling drug-related deaths as a key priority area for innovation in NHS Scotland.

By advancing projects like RescuePatch, MESOX in collaboration with NHS Fife in Scotland continues to make significant strides in addressing some of the most pressing healthcare challenges, demonstrating its commitment to improving patient outcomes and saving lives.

MESOX’s RescuePatch Takes Centre Stage in UK’s Fight Against Drug Overdose Deaths

By |2024-07-13T20:43:53+00:00August 29th, 2023|

MESOX has been selected as a key participant in the UK government's Reducing Drug Deaths Innovation Challenge Phase 1 SBRI programme. Its innovative RescuePatch project, a groundbreaking transdermal patch designed to combat fatal drug overdoses, has been recognized as a standout among the 11 selected projects. RescuePatch is a unique, controlled-release combination patch that delivers [...]

Another achievement for MESOX!

By |2023-05-17T23:58:52+00:00June 18th, 2022|

Your Content Goes Here We're a Finalist! In June 2022, we learnt that MESOX was shortlisted as a Finalist at the RSC’s Emerging Technologies Competition under its Health Category. This is the 10th year for this competition and we are delighted to receive the news at this important time in [...]

Participation at LSX World Congress 2022

By |2022-08-03T10:23:37+00:00June 30th, 2017|

Your Content Goes Here In May 2022, MESOX participated in the activities of the LSX World Congress in London. The meeting brought together executives and leaders from Biotech, Healthtech and Medtech companies to discuss the latest developments in life sciences and partnership opportunities. At the event, our team had the opportunity to [...]